Growth Metrics

Protalix BioTherapeutics (PLX) Total Debt (2011 - 2024)

Protalix BioTherapeutics' quarterly Total Debt came in at $20.4 million in Q2 2024, little changed quarter-over-quarter from $20.4 million in Q1 2024.

Protalix BioTherapeutics has reported Total Debt for 11 years, with the latest figure at $20.4 million in Q2 2024.

  • For the quarter ending Q2 2024, Total Debt changed N/A year-over-year to $20.4 million; the trailing twelve-month figure through Jun 2024 stood at $20.4 million (changed N/A YoY), and the FY2023 full-year result was $20.3 million, changed N/A from the prior year.
  • Total Debt for Q2 2024 stood at $20.4 million, roughly flat from $20.4 million in the prior quarter.
  • The five-year high for Total Debt was $56.4 million in Q2 2021, with the low at $3.2 million in Q3 2021.
  • Average Total Debt over 4 years is $31.3 million, with a median of $20.4 million recorded in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 319.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.96 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.99 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 20.42 Mn
Mar 31, 2024 20.42 Mn
Dec 31, 2023 20.25 Mn
Sep 30, 2023 20.19 Mn
Sep 30, 2021 3.24 Mn
Jun 30, 2021 56.36 Mn
Mar 31, 2021 55.37 Mn
Dec 31, 2020 54.43 Mn
Mar 31, 2018 5.93 Mn
Dec 31, 2017 5.92 Mn
Sep 30, 2017 10.21 Mn
Jun 30, 2017 4.30 Mn
Mar 31, 2017 4.30 Mn
Dec 31, 2016 58.17 Mn
Sep 30, 2016 4.30 Mn
Jun 30, 2016 4.30 Mn
Mar 31, 2016 4.30 Mn
Dec 31, 2015 4.30 Mn
Dec 31, 2013 2.37 Mn
Jun 30, 2013 376,000.00
Mar 31, 2013 2.70 Mn
Dec 31, 2012 5.43 Mn
Sep 30, 2012 2.79 Mn
Jun 30, 2012 4.68 Mn
Dec 31, 2011 6.57 Mn
Sep 30, 2011 4.74 Mn
Jun 30, 2011 4.45 Mn